First Time Loading...

NuVasive Inc
NASDAQ:NUVA

Watchlist Manager
NuVasive Inc Logo
NuVasive Inc
NASDAQ:NUVA
Watchlist
Price: 39.75 USD Market Closed
Updated: Apr 24, 2024

Intrinsic Value

NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. [ Read More ]

The intrinsic value of one NUVA stock under the Base Case scenario is 58.81 USD. Compared to the current market price of 39.75 USD, NuVasive Inc is Undervalued by 32%.

Key Points:
NUVA Intrinsic Value
Base Case
58.81 USD
Undervaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
NuVasive Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NUVA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
NuVasive Inc

Provide an overview of the primary business activities
of NuVasive Inc.

What unique competitive advantages
does NuVasive Inc hold over its rivals?

What risks and challenges
does NuVasive Inc face in the near future?

Has there been any significant insider trading activity
in NuVasive Inc recently?

Summarize the latest earnings call
of NuVasive Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for NuVasive Inc.

Provide P/S
for NuVasive Inc.

Provide P/E
for NuVasive Inc.

Provide P/OCF
for NuVasive Inc.

Provide P/FCFE
for NuVasive Inc.

Provide P/B
for NuVasive Inc.

Provide EV/S
for NuVasive Inc.

Provide EV/GP
for NuVasive Inc.

Provide EV/EBITDA
for NuVasive Inc.

Provide EV/EBIT
for NuVasive Inc.

Provide EV/OCF
for NuVasive Inc.

Provide EV/FCFF
for NuVasive Inc.

Provide EV/IC
for NuVasive Inc.

Show me price targets
for NuVasive Inc made by professional analysts.

What are the Revenue projections
for NuVasive Inc?

How accurate were the past Revenue estimates
for NuVasive Inc?

What are the Net Income projections
for NuVasive Inc?

How accurate were the past Net Income estimates
for NuVasive Inc?

What are the EPS projections
for NuVasive Inc?

How accurate were the past EPS estimates
for NuVasive Inc?

What are the EBIT projections
for NuVasive Inc?

How accurate were the past EBIT estimates
for NuVasive Inc?

Compare the revenue forecasts
for NuVasive Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of NuVasive Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of NuVasive Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of NuVasive Inc compared to its peers.

Compare the P/E ratios
of NuVasive Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing NuVasive Inc with its peers.

Analyze the financial leverage
of NuVasive Inc compared to its main competitors.

Show all profitability ratios
for NuVasive Inc.

Provide ROE
for NuVasive Inc.

Provide ROA
for NuVasive Inc.

Provide ROIC
for NuVasive Inc.

Provide ROCE
for NuVasive Inc.

Provide Gross Margin
for NuVasive Inc.

Provide Operating Margin
for NuVasive Inc.

Provide Net Margin
for NuVasive Inc.

Provide FCF Margin
for NuVasive Inc.

Show all solvency ratios
for NuVasive Inc.

Provide D/E Ratio
for NuVasive Inc.

Provide D/A Ratio
for NuVasive Inc.

Provide Interest Coverage Ratio
for NuVasive Inc.

Provide Altman Z-Score Ratio
for NuVasive Inc.

Provide Quick Ratio
for NuVasive Inc.

Provide Current Ratio
for NuVasive Inc.

Provide Cash Ratio
for NuVasive Inc.

What is the historical Revenue growth
over the last 5 years for NuVasive Inc?

What is the historical Net Income growth
over the last 5 years for NuVasive Inc?

What is the current Free Cash Flow
of NuVasive Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for NuVasive Inc.

Financials

Balance Sheet Decomposition
NuVasive Inc

Current Assets 728.3m
Cash & Short-Term Investments 80.7m
Receivables 267.1m
Other Current Assets 380.4m
Non-Current Assets 1.4B
PP&E 452.6m
Intangibles 808.3m
Other Non-Current Assets 100.4m
Current Liabilities 582.6m
Accounts Payable 118.8m
Accrued Liabilities 60.7m
Short-Term Debt 350m
Other Current Liabilities 53.1m
Non-Current Liabilities 614.4m
Long-Term Debt 446.4m
Other Non-Current Liabilities 168m
Efficiency

Earnings Waterfall
NuVasive Inc

Revenue
1.2B USD
Cost of Revenue
-347.5m USD
Gross Profit
878.7m USD
Operating Expenses
-796.2m USD
Operating Income
82.6m USD
Other Expenses
-54.1m USD
Net Income
28.5m USD

Free Cash Flow Analysis
NuVasive Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

NUVA Profitability Score
Profitability Due Diligence

NuVasive Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Negative Free Cash Flow
Positive Revenue Growth Forecast
49/100
Profitability
Score

NuVasive Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

NUVA Solvency Score
Solvency Due Diligence

NuVasive Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Average Altman Z-Score
46/100
Solvency
Score

NuVasive Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NUVA Price Targets Summary
NuVasive Inc

Wall Street analysts forecast NUVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NUVA is 45 USD .

Lowest
Price Target
Not Available
Average
Price Target
45 USD
13% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NUVA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NUVA Price
NuVasive Inc

1M 1M
-
6M 6M
-
1Y 1Y
-8%
3Y 3Y
-44%
5Y 5Y
-32%
10Y 10Y
+14%
Annual Price Range
39.75
52w Low
36.71
52w High
43.61
Price Metrics
Average Annual Return 0.92%
Standard Deviation of Annual Returns 31.52%
Max Drawdown -60%
Shares Statistics
Market Capitalization 2.1B USD
Shares Outstanding 52 449 200
Percentage of Shares Shorted 15.59%

NUVA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

NuVasive Inc Logo
NuVasive Inc

Country

United States of America

Industry

Health Care

Market Cap

2.1B USD

Dividend Yield

0%

Description

NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. The company is headquartered in San Diego, California and currently employs 2,900 full-time employees. The company went IPO on 2004-05-13. The firm offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, it develops and sells magnetically adjustable implant systems for spine and specialized orthopedic procedures. In addition, it also designs and sells expandable growing rod implant systems for the treatment of early-onset scoliosis, which can be non-invasively lengthened implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control (MAGEC).

Contact

CALIFORNIA
San Diego
7475 Lusk Blvd
+18589091800.0
https://www.nuvasive.com/

IPO

2004-05-13

Employees

2 900

Officers

CEO & Director
Mr. J. Christopher Barry
Exec. VP & CFO
Mr. Matthew K. Harbaugh
Sr. VP of Global Operations
Mr. Dale A. Wolf
Sr. VP, Gen. Counsel & Corp. Sec.
Mr. Nathaniel B. Sisitsky Esq.
VP, Corp. Controller & Chief Accounting Officer
Mr. Marc Rosenbaum
Sr. VP & Chief Technology Officer
Mr. Ryan Donahoe
Show More
Chief Information Officer
Mr. Johnson Lai
VP of Investor Relations
Ms. Juliet C. Cunningham
Sr. VP of People & Culture
Mr. Michael Farrington
Sr. VP of Strategy & Corp. Devel.
Mr. Sean Freeman
Show Less

See Also

Discover More
What is the Intrinsic Value of one NUVA stock?

The intrinsic value of one NUVA stock under the Base Case scenario is 58.81 USD.

Is NUVA stock undervalued or overvalued?

Compared to the current market price of 39.75 USD, NuVasive Inc is Undervalued by 32%.